▲ BUY
7
/ 10
Conviction
$ Value
$25K
Shares
31,250
Price
$1
Filed
Apr 16
▶ Why this score? (7/10)
- ✓ Open market buy (+3)
- ✓ Director (+1)
- ✓ Cluster: 6 insiders buying (+2)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
JAFF MICHAEL R
Title
—
CIK
0001988352
Roles
Director
Transaction Details
Transaction Date
2026-04-16
Code
P
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
31,250
Footnotes
These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026. | The shares are indirectly held by the Reporting Person under the entity Open Book Healthcare.
Filing Info
JAFF MICHAEL R's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-09 | BEAT | A | $0 |
Other Insiders at BEAT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| STROME MARK E | $600K | — | 2026-04-16 |
| Elfrink Willem | $150K | — | 2026-04-16 |
| Ferrari Richard | $50K | — | 2026-04-16 |
| Vajdic Branislav / JAFF MICHAEL R / Cruickshank Tim | $25K | — | 2026-04-16 |
| Ortigas-Wedekind Marga | $20K | — | 2026-04-16 |
|
ENO Robert Paul
President
|
$10K | — | 2026-04-16 |
| de Urioste George | — | — | 2026-02-09 |
|
Vajdic Branislav
President
|
— | — | 2026-02-09 |
| Nelson Kenneth Warwick III | — | — | 2026-02-09 |
| JAFF MICHAEL R | — | — | 2026-02-09 |
|
Cruickshank Tim
CFO
|
— | — | 2026-02-09 |